It was reported that on (b)(6) 2014, a 4.0x23mm xience prime stent was successfully implanted in the proximal left anterior descending (lad) coronary artery lesion.Starting on (b)(6) 2017, the patient experienced intermittent chest tightness (diagnosed as unstable angina) with palpitations and dizziness lasting 5 days.On (b)(6) 2017, the patient was hospitalized for this event and medications were provided.Coronary angiography was not performed.The event resolved and on (b)(6) 2017, the patient was discharged from the hospital.No additional information was provided regarding this issue.
|
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect(s) of angina and arrhythmias are listed in the xience prime, xience prime small vessel (sv), and xience prime long length (ll), everolimus eluting coronary stent systems instructions for use (ifu) as a known patient effect(s) of coronary stenting procedures.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|